Edinburgh-based Craneware plc, a provider of software for the US healthcare market, said its adjusted profit before tax rose 21% to $20.6 million in the six months to December 31, 2024, as revenue jumped 10% to $100 million.

Interim dividend rose 4% to 13.5p per share.

Craneware CEO Keith Neilson said: “We are pleased to have delivered record interim financial results, reflecting the successful execution of our growth strategy. Our trusted position at the heart of the US healthcare market is translating into double digit growth rates, as we support our customers in the transformation of their operations and finance through our software and data driven insights.

“Following the US election, hospitals are now expecting a period where they can focus on their fundamentals and make investments to drive strategic growth, which we anticipate will provide a sustained demand environment for our offerings.

“The continued expansion of our Trisus platform, increasing engagement from major players within the US healthcare market and strong financial foundations mean we are well placed to execute on our ambitious growth strategy, as we support our customers in transforming the business of healthcare.”